← Back to Search

Nightmare Therapy for Nightmares

N/A
Recruiting
Research Sponsored by kathleen mcnamara
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Aged 18 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up screening, visit 1 (week 0), visit 2 (week 2 +/- 1 week), visit 3 (week 4 +/- 1 week), visit 4 (week 6 +/- 1 week)
Awards & highlights
No Placebo-Only Group

Summary

This trialwill test a quick therapy to help people with recurring nightmares in a primary care setting.

Who is the study for?
This trial is for adults aged 18+ who have recurring nightmares at least three times a month and are receiving care at Nellis Air Force Base. Participants must also score at least 15 on specific nightmare distress and frequency tools to qualify.
What is being tested?
The study tests 'Nightmare Rescripting and Rehearsal Therapy' (NRRT), a brief intervention by non-mental health professionals in primary care, against standard sleep hygiene education. The impact on nightmare distress and frequency will be measured over six weeks.
What are the potential side effects?
Since NRRT is a psychological therapy involving no medication, side effects may include temporary increases in distress due to discussing or engaging with nightmare content but typically do not involve physical side effects.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~screening, visit 1 (week 0), visit 2 (week 2 +/- 1 week), visit 3 (week 4 +/- 1 week), visit 4 (week 6 +/- 1 week)
This trial's timeline: 3 weeks for screening, Varies for treatment, and screening, visit 1 (week 0), visit 2 (week 2 +/- 1 week), visit 3 (week 4 +/- 1 week), visit 4 (week 6 +/- 1 week) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Nightmare Frequency in the past week (change from nightmare frequency screening baseline at each 4 visits)
Nightmare distress Questionnaire (change from nightmare distress baseline from screening at each 4 visits)
Secondary study objectives
Beck Depression Inventory II
General Anxiety Disorder (anxiety)
Insomnia Severity Index (insomnia)
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention + Standard of careExperimental Treatment2 Interventions
Nightmare Rescripting and Rehearsal: a 10 minute intervention for Primary Care plus Sleep Hygiene handout.
Group II: Standard of careActive Control1 Intervention
Standard of Care Sleep Hygiene handout alone.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
standard of care
2008
Completed Phase 4
~3640

Find a Location

Who is running the clinical trial?

kathleen mcnamaraLead Sponsor
David MossLead Sponsor
4 Previous Clinical Trials
626 Total Patients Enrolled

Media Library

Nightmare Rescripting and Rehearsal Clinical Trial Eligibility Overview. Trial Name: NCT04529070 — N/A
Sleep Research Study Groups: Intervention + Standard of care, Standard of care
Sleep Clinical Trial 2023: Nightmare Rescripting and Rehearsal Highlights & Side Effects. Trial Name: NCT04529070 — N/A
Nightmare Rescripting and Rehearsal 2023 Treatment Timeline for Medical Study. Trial Name: NCT04529070 — N/A
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top